{"transactions":[{"id":1244451,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-02-26T23:45:30.000Z","date":"2025-02-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":5558,"price":0.476,"value":2645.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2024 pursuant to the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":105862,"source":{"system":"sec-edgar","filing":"0001415889-25-005728","document":"form4-02262025_110226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925005728/form4-02262025_110226.xml","form_type":"4"}},{"id":1268601,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:03:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":360000,"derivative":{"exercise_price":0.476,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001415889-25-004223","document":"form4-02142025_110236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925004223/form4-02142025_110236.xml","form_type":"4"}},{"id":1323497,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-23T21:15:27.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":355000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on December 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of such date."}],"balance_after":355000,"derivative":{"exercise_price":0.4499,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":355000},"source":{"system":"sec-edgar","filing":"0001415889-24-030067","document":"form4-12232024_041224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924030067/form4-12232024_041224.xml","form_type":"4"}},{"id":1639757,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T23:28:57.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":165889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents one-third of the Reporting Person's 2023 annual bonus, which the Compensation Committee of the Issuer determined to pay in the form of a stock option in lieu of cash. 100% of the shares are fully vested as of the date of grant."}],"balance_after":165889,"derivative":{"exercise_price":0.79,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":165889},"source":{"system":"sec-edgar","filing":"0001415889-24-004235","document":"form4-02162024_110237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004235/form4-02162024_110237.xml","form_type":"4"}},{"id":1639756,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T23:28:57.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":315000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2025, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":315000,"derivative":{"exercise_price":0.79,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001415889-24-004235","document":"form4-02162024_110237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004235/form4-02162024_110237.xml","form_type":"4"}},{"id":1639755,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-16T23:28:57.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5891,"price":0.79,"value":4653.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":105420,"source":{"system":"sec-edgar","filing":"0001415889-24-004235","document":"form4-02162024_110237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004235/form4-02162024_110237.xml","form_type":"4"}},{"id":1782494,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-13T12:43:31.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":0.85,"value":425.0,"ownership":{"direct":true},"balance_after":111311,"source":{"system":"sec-edgar","filing":"0001209191-23-049192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123049192/doc4.xml","form_type":"4"}},{"id":1784230,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-11T21:33:02.000Z","date":"2023-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":20492,"price":1.5,"value":30738.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":110811,"source":{"system":"sec-edgar","filing":"0001209191-23-048966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123048966/doc4.xml","form_type":"4"}},{"id":1936184,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T21:16:07.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":90000,"derivative":{"exercise_price":1.43,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-021541","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021541/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":1936183,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-29T21:16:07.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":21300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed solely to correct the number of shares beneficially owned. Due to administrative error the original filing did not include shares purchased under the Issuer's Employee Stock Purchase Plan (\"ESPP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Share balance includes stock purchased under the ESPP not previously reported."}],"balance_after":131303,"source":{"system":"sec-edgar","filing":"0001209191-23-021541","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021541/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":1936182,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-29T21:16:07.000Z","date":"2023-02-15","kind":"grant","planned":false,"acquired":true,"shares":51893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment is being filed solely to correct the number of shares beneficially owned. Due to administrative error the original filing did not include shares purchased under the Issuer's Employee Stock Purchase Plan (\"ESPP\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed solely to correct the number of shares beneficially owned. Due to administrative error the original filing did not include shares purchased under the Issuer's Employee Stock Purchase Plan (\"ESPP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Share balance includes stock purchased under the ESPP not previously reported."}],"balance_after":110003,"source":{"system":"sec-edgar","filing":"0001209191-23-021541","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123021541/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-17"}},{"id":2009492,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T22:00:59.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":90000,"derivative":{"exercise_price":1.43,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-010731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010731/doc4.xml","form_type":"4"}},{"id":2009491,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-17T22:00:59.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":21300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":127307,"source":{"system":"sec-edgar","filing":"0001209191-23-010731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010731/doc4.xml","form_type":"4"}},{"id":2009490,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-17T22:00:59.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":51893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested."}],"balance_after":106007,"source":{"system":"sec-edgar","filing":"0001209191-23-010731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010731/doc4.xml","form_type":"4"}},{"id":2390060,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T23:20:41.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":161600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2023; and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":161600,"derivative":{"exercise_price":4.3,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":161600},"source":{"system":"sec-edgar","filing":"0001209191-22-010976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122010976/doc4.xml","form_type":"4"}},{"id":2390059,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-17T23:20:41.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":53900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2023, February 15, 2024, February 15, 2025 and February 15, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 214 shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":54114,"source":{"system":"sec-edgar","filing":"0001209191-22-010976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122010976/doc4.xml","form_type":"4"}},{"id":2878149,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82794,"kind":"person","name":"Celebi John","position":1,"cik":"0001843539","reported_name":"Celebi John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option  (Right to Buy)","published_at":"2021-02-05T21:37:35.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":416666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the options granted hereby shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, February 3, 2021, thereafter one forty-eighth (1/48th) of the options granted shall vest and become exercisable each month following the Vesting Commencement Date, over four years such that the options shall be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":416666,"derivative":{"exercise_price":19,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":416666},"source":{"system":"sec-edgar","filing":"0001209191-21-008080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919121008080/doc4.xml","form_type":"4"}}]}